Alessandra Capital Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Alessandra Capital Management's BEAM Position: Q3 2026 in Review
Alessandra Capital Management reduced its Beam Therapeutics (BEAM) stake by 47% in Q3 2026, selling an estimated $739K and leaving 30,384 shares worth $743K. The position accounts for 0.52% of the portfolio, ranked #52.
Alessandra Capital Management first reported a position in BEAM in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.95M in Q2 2026. 264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Alessandra Capital Management held 30,384 shares of Beam Therapeutics worth $743K as of Q3 2026.
- Alessandra Capital Management sold 26,561 Beam Therapeutics shares in Q3 2026, an estimated $739K.
- Beam Therapeutics made up 0.52% of Alessandra Capital Management's portfolio in Q3 2026, its #52 holding.
- Alessandra Capital Management first reported a position in Beam Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Alessandra Capital Management's Beam Therapeutics position peaked at $1.95M in Q2 2026.
- 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Alessandra Capital Management's 13F filing for Q3 2026, filed 30 Oct 2026.